Radboud University Nijmegen Medical Centre
Nijmegen, 6500 HB, Netherlands
NCT Number: NCT00184834
An increasing aggressiveness in the surgical approach of colorectal liver metastases is observed. This seems only justified when, besides prolongation of survival, also the health status of patients is considered. The aim of this prospective study is to investigate the impact of surgery on health-related quality of life in this specific patient population operated for colorectal liver metastases.Furthermore, as the indications for hepatic resection are broadened and patients with more extensive liver disease are operated on, the chance of non operable disease at laparotomy will increase. The effects of such an event on HRQol are also studied.
Looking for future studies?
Notify Me0 year and older
All sexes
Observational
Nijmegen, 6500 HB, Netherlands
In a prospective study several patients groups were identified. Patients undergoing liver resection and/or local ablative therapy. Patients with non operable disease at (explorative) laparotomy and outpatients with non operable disease as shown during work up for liver resection. Several validated instruments on HRQoL were ompleted preoperatively (baseline), a half month after operation and then every three months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
colorectal liver metastases (operable and non operable disease) and participation by means of filling in quality of life instruments
Exclusion criteria
drop out and therefore loss of quality of life instruments
Radboud University Medical Center
Other
Quality of Life After Surgical Treatment of Colorectal Liver Metastases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00557557
Colorectal Liver Metastases, Neoplasm Metastasis
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT01255007
Body Weight, Colorectal Liver Metastases
Toronto, Ontario, Canada
View Trial DetailsNCT00942292
Colorectal Liver Metastases, Neoplasm Metastasis
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT00119899
Colonic Diseases, Colorectal Cancer
Nijmegen, Gelderland, Netherlands
View Trial Details